Illinois Tool Works Inc. vs Revolution Medicines Inc. Common Stock — how do they compare? Illinois Tool Works Inc. trades at $264.13 (market cap $74.38B), while Revolution Medicines Inc. Common Stock trades at $189.76 (market cap $40.32B). The key difference: Illinois Tool Works Inc. is the larger of the two by market cap, and Illinois Tool Works Inc. pays a 2.63% dividend while Revolution Medicines Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Illinois Tool Works Inc. for 67 Days and Revolution Medicines Inc. Common Stock for 0 Days on average.
| ITW | RVMD | |
|---|---|---|
Market Cap | $74.38B | $40.32B |
Volume | 1,125,477 | 4,855,734 |
Sector | Industrials | Health |
52-Week High | $299.60 | $221.15 |
52-Week Low | $241.07 | $47.50 |
Typical Hold Time | 67 Days | 0 Days |
Enterprise Value | $83.23B | $37.02B |
Dividend Yield | 2.63% | — |
Signals from Pluang's Aura AI — not financial advice
ITW trades at $264.71, up 1.36% today, with a bearish technical signal but strong fundamental performance. The company reported Q2 2026 EPS of $2.84, beating estimates, and maintains robust profitability with a 19.39% net income margin and 104.65% ROE. Recent news highlights its dividend increase to $1.72 per share and its status as a Dividend King with 59 years of consecutive increases.
The outlook is mixed: strong cash flow and dividend reliability support income investors, but high valuation ratios (P/E 23.65, P/B 25.7) and bearish technicals suggest near-term pressure. Risks include debt levels and sector volatility, while analyst consensus leans hold with a $276.86 price target.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Illinois Tool Works is a diversified global manufacturer that produces specialized industrial equipment, consumables, and related services. The firm operates 87 global divisions through seven distinct operating segments: automotive OEM, construction products, food equipment, specialty products, test/measurement and electronics, polymers and fluids, and welding. About half of its revenue comes from its operations in North America, with the remainder originating from international markets. ITW takes a bottom-up and decentralized approach to portfolio management, with the exception that each segment must apply its 80/20 operating process modeled on the Pareto principle.
Read more on ITW →Revolution Medicines develops precision medicines for cancer. Its programs focus on targeting RAS-driven cancers and related signaling pathways.
Read more on RVMD →